NHS cancer drug approval needs radical change

Telegraph.co.ukNHS cancer drug approval needs radical changeTelegraph.co.ukOlaparib is the first cancer drug to be approved that is directed against an inherited genetic mutation – and its development was underpinned by science, much of which was carried out at The Institute of Cancer Research in London. Research shows it ...Delay in NHS patients' access to cancer drug labelled a 'disgrace'The GuardianCancer drug that DOUBLES life expectancy delayed...because MPs are on seven ...Express.co.ukCancer treatment is delayed for a year by NHS red tapeDaily MailOnMedica -PharmaTimesall 30 news articles »

Share this post